ViroLogic to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference

ViroLogic to Present at Pacific Growth Equities 2005 Life
Sciences Growth Conference 


SO. SAN FRANCISCO, Calif., May 31  /PRNewswire-FirstCall/ -- ViroLogic, Inc.
(NASDAQ:VLGC) announced today that William D. Young, CEO and Chairman of
ViroLogic, is scheduled to present a corporate overview at the Pacific Growth
Equities 2005 Life Sciences Growth Conference at 4:30 p.m. on Monday, June 6th
at the Mark Hopkins Inter-Continental Hotel in San Francisco, CA.

To access the live audio broadcast, or the subsequent archived recording, log
on to the investor relations section of the Company's website at
http://www.virologic.com/. The archived version of the webcast will be
available on the Company's website for one month.

About ViroLogic

ViroLogic is a biotechnology company advancing individualized medicine by
discovering, developing and marketing innovative products to guide and improve
treatment of serious infectious diseases and cancer. The Company's products are
designed to help doctors optimize treatment regimens for their patients that
lead to better outcomes and reduced costs. The Company's technology is also
being used by numerous biopharmaceutical companies to develop new and improved
antiviral therapeutics and vaccines as well as targeted cancer therapeutics.
More information about the Company and its technology can be found on its web
site at http://www.virologic.com/. 

DATASOURCE: ViroLogic, Inc.



CONTACT:  Alfred Merriweather, Vice President and CFO of ViroLogic,

[phone]; or Carolyn Bumgardner Wang of WeissComm Partners,

[phone] or , for ViroLogic



Web site:  http://www.virologic.com/ 

Copyright